Regulus Therapeutics IncEigentümerstruktur
| Preis (2025-06-24) | 52W Hoch | 52W Tief |
| 8.16 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 8,8 USD | 1 | 1 | 4 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 69.234.096 | 3,23 | 1,57 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Regulus Therapeutics Inc
Mitarbeiter 34
Handelsplatz NASDAQ
Ticker Symbol RGLS
IPO Datum 2012-10-04
Adresse 4224 Campus Point Court, San Diego, CA, United States, 92121
Webseite https://www.regulusrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Joseph P. Hagan M.B.A. | CEO & Director |
| 2 | Dr. Preston S. Klassen M.D., M.H.S. | President, Head of Research & Development and Director |
| 3 | Ms. Crispina Calsada CPA | Chief Financial Officer |
| 4 | Mr. Daniel J. Penksa | VP of Finance & Controller |
| 5 | Mr. Christopher Ray Aker J.D. | Senior VP, General Counsel & Corporate Secretary |
| 6 | Dr. Claire Susan Padgett M.S., M.T., Ph.D. | Senior Vice President of Clinical Operations |
| 7 | Dr. Rekha Garg M.D., M.S. | Chief Medical Officer |
| 8 | Mr. Edmund Lee Ph.D. | Vice President of Translational Medicine |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vivo Capital, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 6 | Victory Capital Management Inc. | 0,00% | 0,00 Mio. USD |
| 7 | Wells Fargo & Co | 0,00% | 0,00 Mio. USD |
| 8 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 9 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 10 | Bank of New York Mellon Corp | 0,00% | 0,00 Mio. USD |
| 11 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 12 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 13 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 15 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 16 | Barclays PLC | 0,00% | 0,00 Mio. USD |
| 17 | Rhumbline Advisers | 0,00% | 0,00 Mio. USD |
| 18 | ING Investment Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0,00% | 0,00 Mio. USD |
| 20 | LPL Financial Corp | 0,00% | 0,00 Mio. USD |